• Saturday,June 01,2024
ippcimedia.org
X

Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients

$ 30.99

4.5 (530) In stock

Share

Pruritus in Patients Under Targeted Anticancer Therapy: A

Pruritus related to trastuzumab and pertuzumab in HER2 + breast

Antibody-Based Biotherapeutics in Cancer

A randomized, controlled phase II trial of neoadjuvant ado

Pertuzumab in human epidermal growth-factor receptor 2-positive

Pertuzumab (Perjeta) Drug Information

ESMO: Final Overall Survival Analysis: HER2-Positive Metastatic

Targeted treatments of HER2-positive metastatic breast cancer

Pertuzumab, trastuzumab, and docetaxel for HER2-positive

Skin Lesions in Patient With Metastatic Breast Cancer

PDF] Mechanisms Underlying the Action and Synergism of Trastuzumab

Real World Evidence of Neoadjuvant Docetaxel/Carboplatin

Phase I study of LZM005 in patients with HER2-positive metastatic